{"id":"W2323802693","doi":"10.3899/jrheum.120249","title":"Infliximab in Psoriatic Arthritis","year":2012,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Placebo; Psoriasis; Rheumatology; Internal medicine; Rheumatoid arthritis; Adverse effect; TNF inhibitor; Adalimumab; Etanercept; Randomized controlled trial; Arthritis; Gastroenterology; Tumor necrosis factor alpha; Dermatology; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009971239,0.0007533995,0.001137788,0.0007211541,0.0002830143,0.0008147858,0.0004009129,0.001551723,0.01499443],"category_scores_gemma":[0.001498323,0.0001369764,0.0006171339,0.0008190419,0.0002944758,0.0004953747,0.0004239245,0.002673452,0.01253633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005755707,"about_ca_system_score_gemma":0.0004628084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000584522,"about_ca_topic_score_gemma":0.00111211,"domain_scores_codex":[0.9994276,0.0002021286,0.00008781174,0.00006866481,0.0001577067,0.00005615344],"domain_scores_gemma":[0.9994211,0.0001751578,0.0001497171,0.00003374019,0.0001316641,0.00008863164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001080639,0.0002173962,0.0008244978,0.004820147,0.0001961985,0.001475205,0.00006436461,0.0001946483,0.002151447,0.003228263,0.1038467,0.8819005],"study_design_scores_gemma":[0.001086739,0.0009973269,0.005552342,0.002179169,0.0002574351,0.007093905,0.00003301044,0.0001856472,0.0008619498,0.00235064,0.9793769,0.00002494874],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00329766,0.95217,0.0008143155,0.01204232,0.005728177,0.00006721981,0.0002591519,0.0001225307,0.02549874],"genre_scores_gemma":[0.06583595,0.832715,0.003356712,0.03119319,0.0187922,0.000298821,0.001348302,0.00006086256,0.04639899],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01499443,"threshold_uncertainty_score":0.05016142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04221363469434143,"score_gpt":0.3549296525239564,"score_spread":0.3127160178296149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}